 | Up a level |
Gil-Jimenez, Alberto; van Dorp, Jeroen; Contreras-Sanz, Alberto; van der Vos, Kristan; Vis, Daniel J; Braaf, Linde; Broeks, Annegien; Kerkhoven, Ron; van Kessel, Kim E M; Ribal, María José; Alcaraz, Antonio; Wessels, Lodewyk F A; Seiler, Roland; Wright, Jonathan L; Mengual, Lourdes; Boormans, Joost; van Rhijn, Bas W G; Black, Peter C; van der Heijden, Michiel S (2023). Corrigendum to "Assessment of Predictive Genomic Biomarkers for Response to Cisplatin-based Neoadjuvant Chemotherapy in Bladder Cancer" [Eur Urol 2023;83:313-17]. European urology, 83(6), e165. Elsevier 10.1016/j.eururo.2023.03.002
Gil-Jimenez, Alberto; van Dorp, Jeroen; Contreras-Sanz, Alberto; van der Vos, Kristan; Vis, Daniel J; Braaf, Linde; Broeks, Annegien; Kerkhoven, Ron; van Kessel, Kim E M; Ribal, María José; Alcaraz, Antonio; Wessels, Lodewyk F A; Seiler, Roland; Wright, Jonathan L; Mengual, Lourdes; Boormans, Joost; van Rhijn, Bas W G; Black, Peter C; van der Heijden, Michiel S (2023). Assessment of Predictive Genomic Biomarkers for Response to Cisplatin-based Neoadjuvant Chemotherapy in Bladder Cancer. European urology, 83(4), pp. 313-317. Elsevier 10.1016/j.eururo.2022.07.023
Grivas, Petros; Bismar, Tarek A; Alva, Aijai S; Huang, Huei-Chung; Liu, Yang; Seiler, Roland; Alimohamed, Nimira; Cheng, Liang; Hyndman, M Eric; Dabbas, Bashar; Black, Peter C; Davicioni, Elai; Wright, Jonathan L; Ornstein, Moshe C; Mian, Omar Y; Kaimakliotis, Hristos Z; Gibb, Ewan A; Lotan, Yair (2020). Validation of a neuroendocrine-like classifier confirms poor outcomes in patients with bladder cancer treated with cisplatin-based neoadjuvant chemotherapy. Urologic oncology, 38(4), pp. 262-268. Elsevier 10.1016/j.urolonc.2019.11.004
de Jong, Joep J; Liu, Yang; Robertson, A Gordon; Seiler, Roland; Groeneveld, Clarice S; van der Heijden, Michiel S; Wright, Jonathan L; Douglas, James; Dall'Era, Marc; Crabb, Simon J; van Rhijn, Bas W G; van Kessel, Kim E M; Davicioni, Elai; Castro, Mauro A A; Lotan, Yair; Zwarthoff, Ellen C; Black, Peter C; Boormans, Joost L; Gibb, Ewan A (2019). Long non-coding RNAs identify a subset of luminal muscle-invasive bladder cancer patients with favorable prognosis. Genome medicine, 11(1), p. 60. BioMed Central 10.1186/s13073-019-0669-z
Seiler, Roland; Gibb, Ewan A; Wang, Natalie Q; Oo, Htoo Zarni; Lam, Hung-Ming; Van Kessel, Kim E; Winters, Brian; Erho, Nicholas G; Takhar, Mandeep M; Douglas, James; Vakar-Lopez, Funda; van Rhijn, Bas W G; Fransen van de Putte, Elisabeth E; Zwarthoff, Ellen C; Thalmann, George; Boormans, Joost L; Dall'Era, Marc; van der Heijden, Michiel S; Wright, Jonathan L and Black, Peter C (2019). Divergent biological response to neoadjuvant chemotherapy in muscle-invasive bladder cancer. Clinical cancer research, 25(16), pp. 5082-5093. American Association for Cancer Research 10.1158/1078-0432.CCR-18-1106
Winters, Brian R; Vakar-Lopez, Funda; Brown, Lisha; Montgomery, Bruce; Seiler, Roland; Black, Peter C; Boormans, Joost L; Dall Era, Marc; Davincioni, Elai; Douglas, James; Gibb, Ewan A; van Rhijn, Bas W G; van der Heijden, Michiel S; Hsieh, Andrew C; Wright, Jonathan L; Lam, Hung-Ming (2018). Mechanistic target of rapamycin (MTOR) protein expression in the tumor and its microenvironment correlates with more aggressive pathology at cystectomy. Urologic oncology - seminars and original investigations, 36(7), 342.e7-342.e14. Elsevier 10.1016/j.urolonc.2018.03.016
